Cargando…
Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
Anti-TNFα therapy has revolutionized the treatment of rheumatoid arthritis (RA) and other inflammatory diseases. These drugs are powerful and expensive. A new anti-TNFα agent, a nanomolecule comprising a humanized Fab’ antibody fragment against TNFα with a polyethylene glycol tail, is shortly to com...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673817/ https://www.ncbi.nlm.nih.gov/pubmed/17722505 |